Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (240) 240
polyglactin 910 - chemistry (221) 221
index medicus (200) 200
humans (159) 159
pharmacology & pharmacy (104) 104
nanoparticles (92) 92
mice (90) 90
male (87) 87
rats (81) 81
polyethylene glycols - chemistry (79) 79
materials science, biomaterials (75) 75
female (73) 73
poly (73) 73
microspheres (72) 72
particle size (71) 71
engineering, biomedical (70) 70
nanoparticles - chemistry (68) 68
in-vitro (67) 67
drug delivery systems (60) 60
drug carriers - chemistry (59) 59
drug-delivery (56) 56
polyglactin 910 (55) 55
polyglactin 910 - metabolism (48) 48
delivery (43) 43
polyglactin 910 - pharmacology (43) 43
cell line, tumor (42) 42
microscopy, electron, scanning (42) 42
plga (42) 42
tissue engineering (39) 39
cells, cultured (38) 38
rabbits (38) 38
drugs (37) 37
polymers (37) 37
chemistry, multidisciplinary (36) 36
surface properties (36) 36
analysis (35) 35
in-vivo (35) 35
cells (34) 34
time factors (34) 34
release (33) 33
cell line (32) 32
cancer (31) 31
surgery (31) 31
rats, sprague-dawley (30) 30
tissue scaffolds - chemistry (30) 30
polyglactin 910 - administration & dosage (28) 28
drug delivery systems - methods (27) 27
vehicles (27) 27
drug carriers (26) 26
nanoscience & nanotechnology (26) 26
article (25) 25
biocompatible materials - chemistry (25) 25
drug delivery (25) 25
plga nanoparticles (25) 25
regeneration (25) 25
polymers - chemistry (24) 24
biocompatible materials (22) 22
biotechnology & applied microbiology (22) 22
cell proliferation - drug effects (22) 22
materials testing (22) 22
mice, inbred balb c (22) 22
polyglactin 910 - pharmacokinetics (22) 22
rats, wistar (22) 22
therapy (22) 22
biodegradation, environmental (21) 21
drug compounding (21) 21
kinetics (21) 21
tissue distribution (21) 21
cell biology (20) 20
growth (20) 20
medicine, research & experimental (20) 20
scaffolds (20) 20
solubility (20) 20
stem cells (20) 20
tissue (20) 20
cell proliferation (19) 19
cell survival - drug effects (19) 19
nanoparticles - administration & dosage (19) 19
porosity (19) 19
biocompatibility (18) 18
biomedical materials (18) 18
chitosan (18) 18
degradation (18) 18
lactic acid - chemistry (18) 18
mice, nude (18) 18
peptides (18) 18
tissue engineering - methods (18) 18
cell survival (17) 17
delayed-action preparations (17) 17
expression (17) 17
lactid (17) 17
microparticles (17) 17
cell adhesion (16) 16
copolymer (16) 16
delayed-action preparations - chemistry (16) 16
disease models, animal (16) 16
drug liberation (16) 16
micelles (16) 16
nanoparticles - ultrastructure (16) 16
polyethylene glycol (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle
by Miller, Miles A and Gadde, Suresh and Pfirschke, Christina and Engblom, Camilla and Sprachman, Melissa M and Kohler, Rainer H and Yang, Katherine S and Laughney, Ashley M and Wojtkiewicz, Gregory and Kamaly, Nazila and Bhonagiri, Sushma and Pittet, Mikael J and Farokhzad, Omid C and Weissleder, Ralph
Science Translational Medicine, ISSN 1946-6234, 11/2015, Volume 7, Issue 314, pp. 314ra183 - 314ra183
Therapeutic nanoparticles (TNPs) have shown heterogeneous responses in human clinical trials, raising questions of whether imaging should be used to identify... 
Paclitaxel - metabolism | Predictive Value of Tests | Humans | Ovarian Neoplasms - pathology | Magnetic Resonance Imaging - methods | Tumor Microenvironment | Polyethylene Glycols - chemistry | Ferrosoferric Oxide - metabolism | Fibrosarcoma - metabolism | Polyglactin 910 - metabolism | Nanoparticles | Ovarian Neoplasms - genetics | Tissue Distribution | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Fibrosarcoma - pathology | Time Factors | Female | Antineoplastic Agents, Phytogenic - metabolism | Ovarian Neoplasms - metabolism | Polyglactin 910 - chemistry | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Polyethylene Glycols - metabolism | Mice, Inbred C57BL | Antineoplastic Agents, Phytogenic - chemistry | Mice, Transgenic | Ferrosoferric Oxide - chemistry | Chemistry, Pharmaceutical | Disease Progression | Particle Size | Xenograft Model Antitumor Assays | Fibrosarcoma - genetics | Macrophages - metabolism | Animals | Mice, Nude | Magnetics - methods | Nanomedicine - methods | Cell Line, Tumor | Mice, Inbred BALB C | DNA Damage | Fibrosarcoma - drug therapy | MEDICINE, RESEARCH & EXPERIMENTAL | LUNG-CANCER | LIPOSOMAL DOXORUBICIN | DRUG-DELIVERY | IN-VIVO | SIZE | FERUMOXYTOL | VASCULAR-PERMEABILITY | ACCUMULATION | CELL | TUMORS | CELL BIOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Nanoparticle penetration of human cervicovaginal mucus: The effect of polyvinyl alcohol
by Yang, Ming and Lai, Samuel K and Yu, Tao and Wang, Ying-Ying and Happe, Christina and Zhong, Weixi and Zhang, Michael and Anonuevo, Abraham and Fridley, Colleen and Hung, Amy and Fu, Jie and Hanes, Justin
Journal of Controlled Release, ISSN 0168-3659, 10/2014, Volume 192, pp. 202 - 208
Therapeutic nanoparticles must rapidly penetrate the mucus secretions lining the surfaces of the respiratory, gastrointestinal and cervicovaginal tracts to... 
Drug delivery | Mucoadhesion | Mucus-penetrating particles | Surfactant | Biodegradable polymers | HYDROPHOBIC DRUGS | PARTICLES | PHARMACOLOGY & PHARMACY | RAPIDLY PENETRATE | BIODEGRADABLE POLYMER NANOPARTICLES | ORAL DELIVERY | CHEMISTRY, MULTIDISCIPLINARY | Polyethylene Glycols - metabolism | Polyvinyl Alcohol - chemistry | Drug Carriers - metabolism | Nanoparticles - chemistry | Adhesiveness | Humans | Coated Materials, Biocompatible - chemistry | Coated Materials, Biocompatible - metabolism | Polyethylene Glycols - chemistry | Polyglactin 910 - metabolism | Polyvinyl Alcohol - metabolism | Drug Carriers - chemistry | Polyesters - chemistry | Polyesters - metabolism | Cervix Mucus - metabolism | Nanoparticles - metabolism | Polyglactin 910 - chemistry | Surface active agents | Polyols | mucus-penetrating particles | mucoadhesion | biodegradable polymers | surfactant
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery
by Cu, Yen and Booth, Carmen J and Saltzman, W. Mark
Journal of Controlled Release, ISSN 0168-3659, 2011, Volume 156, Issue 2, pp. 258 - 264
Intravaginal (ivag) delivery, which is a proven way to confer local protection against STDs contracted via the reproductive tract, is complicated by the mucus... 
Fluorescence | Surface modification | Intravaginal delivery | Mucosal | Nanoparticle | MICROSPHERES | DRUG-DELIVERY | RATS | MUCOSAL VACCINATION | BIODEGRADABLE NANOPARTICLES | CHEMISTRY, MULTIDISCIPLINARY | IMMUNIZATION | TRANSPORT | MOUSE VAGINA | PHARMACOLOGY & PHARMACY | HUMAN MUCUS | DERIVATIVES | Polyethylene Glycols - metabolism | Drug Carriers - metabolism | Nanoparticles - chemistry | Mice, Inbred C57BL | Coumarins - administration & dosage | Nanoparticles - ultrastructure | Administration, Intravaginal | Polyethylene Glycols - chemistry | Thiazoles - administration & dosage | Polyglactin 910 - metabolism | Vagina - ultrastructure | Drug Carriers - chemistry | Animals | Avidin - chemistry | Female | Vagina - metabolism | Mice | Polyglactin 910 - chemistry | Nanoparticles | nanoparticle | intravaginal delivery | fluorescence | surface modification | mucosal
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium
by Gholizadeh, Shima and Kamps, Jan. A.A.M and Hennink, Wim E and Kok, Robbert J
International Journal of Pharmaceutics, ISSN 0378-5173, 09/2018, Volume 548, Issue 2, pp. 747 - 758
Dactolisib (NVP-BEZ235, also referred to as: ′BEZ235′ or ′BEZ′) is a dual mTOR/PI3 K inhibitor that is of potential interest in the treatment of inflammatory... 
Nanoparticles | NVP-BEZ235 | Inflammation | PLGA | Targeted delivery | DRUG-DELIVERY | PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET | CANCER | IN-VITRO DEGRADATION | SAINT-O-SOMES | CELL-MIGRATION | SELECTIVE DELIVERY | PHARMACOLOGY & PHARMACY | RAPAMYCIN INHIBITOR | PI3K/AKT/MTOR PATHWAY | Polyethylene Glycols - metabolism | Human Umbilical Vein Endothelial Cells - drug effects | Enzyme Inhibitors - metabolism | Human Umbilical Vein Endothelial Cells - metabolism | Humans | Imidazoles - administration & dosage | Endothelium, Vascular - drug effects | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Polyglactin 910 - metabolism | Quinolines - administration & dosage | Polyethylene Glycols - administration & dosage | Enzyme Inhibitors - administration & dosage | Quinolines - metabolism | Inflammation - metabolism | Endothelium, Vascular - metabolism | Inflammation - drug therapy | Nanoparticles - metabolism | Nanoparticles - administration & dosage | X-Ray Diffraction - methods | Drug Delivery Systems - methods | Polyglactin 910 - administration & dosage | Imidazoles - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA-PEG Nanoparticles
by Shanta Dhar and Frank X. Gu and Robert Langer and Omid C. Farokhzad and Stephen J. Lippard
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2008, Volume 105, Issue 45, pp. 17356 - 17361
Cisplatin is used to treat a variety of tumors, but dose limiting toxicities or intrinsic and acquired resistance limit its application in many types of cancer... 
Nanoparticles | Encapsulation | Antigens | HT29 cells | Platinum | Polymers | Prostate cancer | Controlled release | Cancer | Tumors | DNA cross-link | PSMA | Metals in medicine | VITRO | MEMBRANE ANTIGEN | DRUG-DELIVERY | MULTIDISCIPLINARY SCIENCES | COMPLEXES | NEOVASCULATURE | TUMOR | controlled release | THERAPY | IN-VIVO | metals in medicine | SYSTEMS | MPEG NANOPARTICLES | Polyethylene Glycols - metabolism | Nanotechnology - methods | Humans | Aptamers, Nucleotide - therapeutic use | Male | Polyglactin 910 - metabolism | Platinum Compounds | Cisplatin - administration & dosage | Endocytosis - physiology | Aptamers, Nucleotide - genetics | Cisplatin - therapeutic use | Nanoparticles - therapeutic use | Fluorescent Antibody Technique | Cell Line, Tumor | Molecular Structure | Prodrugs - therapeutic use | Drug Delivery Systems - methods | Microscopy, Fluorescence | Prostatic Neoplasms - drug therapy | Usage | Drug targeting | Dosage and administration | Equipment and supplies | Drug therapy | Cisplatin | Methods | Index Medicus | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Mucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drug
by Park, Chun Gwon and Park, Min and Park, Ki Ho and Kim, Myung Hun and Kim, Young Kook and Kim, Mi Jeung and Lee, Seung Ho and Lee, Won Seok and Choi, Sung Yoon and Chung, You Jung and Jung, Young Eun and Choy, Young Bin
Journal of Controlled Release, ISSN 0168-3659, 12/2015, Volume 220, Issue Pt A, pp. 180 - 188
Topical drug administration to the eye is limited by low drug bioavailability due to its rapid clearance from the preocular surface. Thus, multiple daily... 
Glaucoma | Drug delivery | Mucosal adhesion | Ophthalmology | Microparticles | Nanostructured surface | POLYMERS | DELIVERY SYSTEMS | MICROSPHERES | RELEASE | MODEL | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | IN-VITRO | PLGA | CO-GLYCOLIC ACID | PHARMACOLOGY & PHARMACY | BRIMONIDINE TARTRATE | Administration, Ophthalmic | Adrenergic alpha-2 Receptor Agonists - chemistry | Adrenergic alpha-2 Receptor Agonists - pharmacokinetics | Polyglactin 910 - toxicity | Biological Availability | Male | Polyethylene Glycols - chemistry | Polyglactin 910 - metabolism | Drug Carriers | Aqueous Humor - metabolism | Nanoparticles | Adrenergic alpha-2 Receptor Agonists - administration & dosage | Drug Compounding | Ophthalmic Solutions | Mucus - metabolism | Polyglactin 910 - chemistry | Polyethylene Glycols - metabolism | Rabbits | Adhesiveness | Solubility | Glaucoma - drug therapy | Technology, Pharmaceutical - methods | Polyethylene Glycols - toxicity | Animals | Brimonidine Tartrate - chemistry | Brimonidine Tartrate - pharmacokinetics | Brimonidine Tartrate - administration & dosage | Nanotechnology | Drugs | Drug delivery systems | Ophthalmic drugs | Drug therapy | Polyols | Vehicles | Medical colleges | Polyethylene glycol | Brimonidine | Patient compliance | Biomedical engineering
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Injectable biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: Synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels
by Qiao, Mingxi and Chen, Dawei and Ma, Xichen and Liu, Yanjun
International Journal of Pharmaceutics, ISSN 0378-5173, 2005, Volume 294, Issue 1, pp. 103 - 112
Injectable biodegradable temperature-responsive poly( -lactide-co-glycolide-b–ethylene glycol-b- -lactide-co-glycolide) (PLGA–PEG–PLGA) triblock copolymers... 
Drug release | Temperature-responsive | Injection | Hydrogel | TRIBLOCK COPOLYMER | POLOXAMER-407 | GEL MATRIX | BLOCK-COPOLYMERS | DELIVERY SYSTEMS | hydrogel | temperature-responsive | STABILITY | PHARMACOLOGY & PHARMACY | MICELLES | drug release | injection | Polyethylene Glycols - metabolism | Injections | Temperature | Polyglactin 910 - chemical synthesis | Hydrogels - chemical synthesis | Polyethylene Glycols - chemical synthesis | Hydrogels - metabolism | Polyglactin 910 - metabolism | Absorbable Implants | Nuclear magnetic resonance | Indomethacin | Polyethylene glycol | Fluorouracil
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Stabilization of proteins encapsulated in injectable poly (lactide- co -glycolide)
by Mallery, Susan R and Zhu, Gaozhong and Schwendeman, Steven P
Nature Biotechnology, ISSN 1087-0156, 01/2000, Volume 18, Issue 1, pp. 52 - 57
Controlled release from biodegradable polymers is a novel approach to replace daily painful injections of protein drugs. A major obstacle to development of... 
Aggregation | Protein delivery | Bovine serum albumin | Poly(DL-lactide-co- glycolide | Stabilization | stabilization | BIODEGRADABLE MICROSPHERES | BONE MORPHOGENETIC PROTEIN-2 | aggregation | MOISTURE-INDUCED AGGREGATION | poly(DL-lactide-co-glycolide) | DELIVERY | protein delivery | FORMULATIONS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DEGRADATION | FIBROBLAST GROWTH-FACTOR | MICROENCAPSULATION | ALBUMIN | SUSTAINED-RELEASE | bovine serum albumin | Disulfides - metabolism | Solubility - drug effects | Protein Denaturation - drug effects | Molecular Weight | Hydrolysis - drug effects | Protein Conformation - drug effects | Serum Albumin - administration & dosage | Polyglactin 910 - metabolism | Microspheres | Bone Morphogenetic Proteins - metabolism | Osmolar Concentration | Computer Simulation | Isoelectric Point | Proteins - administration & dosage | Fibroblast Growth Factor 2 - metabolism | Polyglactin 910 - chemistry | Antacids - pharmacology | Serum Albumin - chemistry | Polyglactin 910 - administration & dosage | Transforming Growth Factor beta | Peptide Fragments - metabolism | Bone Morphogenetic Proteins - administration & dosage | Bone Morphogenetic Protein 2 | Drug Stability | Water - metabolism | Fibroblast Growth Factor 2 - administration & dosage | Peptide Fragments - chemistry | Animals | Proteins - metabolism | Mice | Proteins - chemistry | Delayed-Action Preparations | 3T3 Cells | Hydrogen-Ion Concentration | Serum Albumin - metabolism | fibroblast growth factor | bone morphogenetic protein 2 | microspheres | polylactide-co-glycolide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing
by Du, Jing and Sun, Ying and Shi, Qiu-Sheng and Liu, Pei-Feng and Zhu, Ming-Jie and Wang, Chun-Hui and Du, Lian-Fang and Duan, You-Rong
International Journal of Molecular Sciences, ISSN 1422-0067, 2012, Volume 13, Issue 1, pp. 516 - 533
Degradation of mRNA by RNA interference is one of the most powerful and specific mechanisms for gene silencing. However, insufficient cellular uptake and poor... 
GFP | Nanoparticles | Gene silencing | PLL | SiRNA delivery | PLGA | THERAPEUTICS | TRANSFECTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | REVOLUTION | gene silencing | CARRIERS | CANCER | CHEMISTRY, MULTIDISCIPLINARY | nanoparticles | THERAPY | DNA | siRNA delivery | EXPRESSION | LIPOSOMES | Polyethylene Glycols - metabolism | Biocompatible Materials - metabolism | Cell Survival - drug effects | RNA, Small Interfering - genetics | Carbocyanines - chemistry | Nanoparticles - chemistry | Biocompatible Materials - chemistry | Humans | Polyglactin 910 - toxicity | Polyethylene Glycols - chemistry | Polyethylene Glycols - toxicity | Polyglactin 910 - metabolism | Nanoparticles - toxicity | Biocompatible Materials - toxicity | Drug Carriers - chemistry | Particle Size | Lipids - chemistry | Transfection | RNA Interference | Nanoparticles - metabolism | Cell Line, Tumor | Polyglactin 910 - chemistry | Microscopy, Fluorescence | RNA, Small Interfering - metabolism | Encapsulation | Flow cytometry | Scanning electron microscopy | Particle size | Surface charge | Biodegradability | Lung cancer | RNA-mediated interference | Cytotoxicity | mRNA | siRNA | High-performance liquid chromatography | Copolymers | Zeta potential | Green fluorescent protein | Physicochemical properties
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates
by Pearson, Ryan M and Casey, Liam M and Hughes, Kevin R and Wang, Leon Z and North, Madeleine G and Getts, Daniel R and Miller, Stephen D and Shea, Lonnie D
Molecular Therapy, ISSN 1525-0016, 07/2017, Volume 25, Issue 7, pp. 1655 - 1664
Polymeric nanoparticles (NPs) have demonstrated their potential to induce antigen (Ag)-specific immunological tolerance in multiple immune models and are at... 
bioconjugation | immune tolerance | regulatory T cells | multiple sclerosis | nanoparticle | drug delivery | autoimmune disease | MEDICINE, RESEARCH & EXPERIMENTAL | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | BONE-MARROW | INDUCTION | IMMUNOLOGICAL-TOLERANCE | TRANSPLANTATION | PLATFORM | CODELIVERY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DISEASE | GENETICS & HEREDITY | REGULATORY T-CELLS | IMMUNE TOLERANCE | Forkhead Transcription Factors - immunology | Myelin Proteolipid Protein - immunology | Spleen - immunology | Nanoparticles - chemistry | Ovalbumin - immunology | Encephalomyelitis, Autoimmune, Experimental - immunology | Delayed-Action Preparations - chemistry | Spleen - drug effects | Polyglactin 910 - metabolism | T-Lymphocytes, Regulatory - pathology | Delayed-Action Preparations - administration & dosage | Myelin Proteolipid Protein - pharmacology | T-Lymphocytes, Regulatory - immunology | Immunoconjugates - pharmacology | Interleukin-2 Receptor alpha Subunit - genetics | Female | Encephalomyelitis, Autoimmune, Experimental - genetics | Polyglactin 910 - chemistry | Myelin Proteolipid Protein - chemistry | Spleen - pathology | Ovalbumin - chemistry | CD4 Antigens - genetics | Immune Tolerance - drug effects | Interleukin-2 Receptor alpha Subunit - immunology | Biomarkers - metabolism | CD4 Antigens - immunology | Gene Expression | Encephalomyelitis, Autoimmune, Experimental - pathology | Immunoconjugates - metabolism | Mice, Inbred C57BL | Forkhead Transcription Factors - genetics | Ovalbumin - pharmacology | Immunoconjugates - chemistry | Antigens - chemistry | Particle Size | Encephalomyelitis, Autoimmune, Experimental - therapy | T-Lymphocytes, Regulatory - drug effects | Animals | Antigens - immunology | Mice | Nanoparticles - administration & dosage | Primary Cell Culture | Antigens - pharmacology | Animal models | Multiple sclerosis | Nuclear magnetic resonance--NMR | Encephalomyelitis | Transplants & implants | Disease | Peptides | Lymphocytes T | Nanoparticles | Developmental stages | Lymphocytes | CD25 antigen | Foxp3 protein | Polymers | Antigens | T cell receptors | Immunological tolerance | Experimental allergic encephalomyelitis | Investigations | CD4 antigen | Immunogenicity | Poly(lactide-co-glycolide) | Autoimmune diseases | Physicochemical properties | Methods | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance
by Kuo, Robert and Saito, Eiji and Miller, Stephen D and Shea, Lonnie D
Molecular Therapy, ISSN 1525-0016, 07/2017, Volume 25, Issue 7, pp. 1676 - 1685
Targeted approaches to treat autoimmune diseases would improve upon current therapies that broadly suppress the immune system and lead to detrimental side... 
tolerance induction mechanism | antigen-specific tolerance | immune tolerance | PLGA | PLG nanoparticles | MEDICINE, RESEARCH & EXPERIMENTAL | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | DENDRITIC CELLS | ANTIGENS | IL-10 | IMMUNOLOGICAL-TOLERANCE | DELIVERY | RESPONSES | MULTIPLE-SCLEROSIS | PATHWAY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | CROSS-PRESENTATION | B7-2 Antigen - genetics | Myelin Proteolipid Protein - immunology | B7-1 Antigen - genetics | Spleen - immunology | Nanoparticles - chemistry | Ovalbumin - immunology | Encephalomyelitis, Autoimmune, Experimental - immunology | Delayed-Action Preparations - chemistry | Spleen - drug effects | Polyglactin 910 - metabolism | T-Lymphocytes, Regulatory - pathology | Delayed-Action Preparations - administration & dosage | Myelin Proteolipid Protein - pharmacology | T-Lymphocytes, Regulatory - immunology | Antigen-Presenting Cells - pathology | Immunoconjugates - pharmacology | Female | CD40 Antigens - genetics | Encephalomyelitis, Autoimmune, Experimental - genetics | Polyglactin 910 - chemistry | B7-2 Antigen - immunology | Myelin Proteolipid Protein - chemistry | Spleen - pathology | Ovalbumin - chemistry | Immune Tolerance - drug effects | Gene Expression | Encephalomyelitis, Autoimmune, Experimental - pathology | B7-1 Antigen - immunology | Immunoconjugates - metabolism | Antigen-Presenting Cells - drug effects | Mice, Inbred C57BL | Ovalbumin - pharmacology | Antigen-Presenting Cells - immunology | Immunoconjugates - chemistry | Antigens - chemistry | Particle Size | Encephalomyelitis, Autoimmune, Experimental - therapy | T-Lymphocytes, Regulatory - drug effects | Animals | Antigens - immunology | Mice | Nanoparticles - administration & dosage | Primary Cell Culture | Antigens - pharmacology | CD40 Antigens - immunology | Cell proliferation | Multiple sclerosis | Transcription factors | CD40 antigen | Disease | Peptides | CD86 antigen | Lymphocytes T | Nanoparticles | Myelin proteolipid protein | Lymphocytes | Localization | Immune system | Antigen presentation | Cytokines | Dendritic cells | Myelin | CD80 antigen | Inflammation | T cell receptors | Immunological tolerance | Studies | Major histocompatibility complex | Antigen-presenting cells | Internalization | PD-L1 protein | Proteolipid protein | Poly(lactide-co-glycolide) | Autoimmune diseases | Apoptosis | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Protein-loaded PLGA–PEG–PLGA microspheres: A tool for cell therapy
by Tran, Van-Thanh and Karam, Jean-Pierre and Garric, Xavier and Coudane, Jean and Benoît, Jean-Pierre and Montero-Menei, Claudia N and Venier-Julienne, Marie-Claire
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 2012, Volume 45, Issue 1, pp. 128 - 137
A promising strategy to repair injured organs is possible by delivering a growth factor poly-( , lactide- -glycolide) (PLGA) microspheres; the latter are... 
PLGA–PEG–PLGA | Poloxamer 188 | Controlled protein release | Lysozyme | Cell adhesion | PLGA-PEG-PLGA | STEM-CELLS | ABA-TRIBLOCK COPOLYMERS | DELIVERY SYSTEMS | PHARMACOLOGICALLY ACTIVE MICROCARRIERS | STABILITY | B-BLOCKS | A-BLOCKS | RELEASE | IN-VITRO | PHARMACOLOGY & PHARMACY | DIFFERENTIATION | Molecular Weight | Humans | Polyethylene Glycols - chemistry | Polyglactin 910 - metabolism | Tissue Scaffolds - chemistry | Microspheres | Surface Properties | Protein Denaturation | Polyglactin 910 - chemistry | Biomimetic Materials - chemistry | Poloxamer - chemistry | Polyethylene Glycols - metabolism | Tissue Engineering - methods | Bone Marrow Cells - cytology | Cell Survival | Stromal Cells - metabolism | Cells, Cultured | Solubility | Cell Adhesion | Fibronectins - metabolism | Biomimetic Materials - metabolism | Adsorption | Fibronectins - chemistry | Hydrophobic and Hydrophilic Interactions | Bone Marrow Cells - metabolism | Stromal Cells - cytology | Hydrogen-Ion Concentration
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights